Drug Trial Radar · NCT07278362
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Last checked: Nov 20, 2026Latest source record: Nov 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
35
Planned (sponsor's estimate)
Start
Nov 30, 2026
Primary completion
May 31, 2031
Study completion May 31, 2032
Sponsor
- Lead sponsor
- University of MiamiAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 12, 2025
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Conditions
- Prostate Cancer
- Hypogonadism, Male
Interventions
Testosterone cypionateDrug
Participants will self-inject 100mg of testosterone cypionate once per week for 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Participants with Disease Progression Within 12 Months After Initiating TRTTime frame: 12 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Desai Sethi Urology Institute
Miami, Florida · Recruiting
Sylvester Comprehensive Cancer Center
Miami, Florida · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.